{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:59:17Z","timestamp":1792519157957,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":215,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmc.2023.117179","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T11:18:09Z","timestamp":1674299889000},"page":"117179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors"],"prefix":"10.1016","volume":"80","author":[{"given":"Nicoletta","family":"Brindani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Munaf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Menichetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Ottonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Armirotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117179_b0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/d41586-021-00396-2","article-title":"The coronavirus is here to stay - here's what that means","volume":"590","author":"Phillips","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117179_b0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117179_b0015","unstructured":"https:\/\/covid19.who.int\/."},{"key":"10.1016\/j.bmc.2023.117179_b0020","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: Drug targets and potential treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0025","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-03592-2","article-title":"Omicron is supercharging the COVID vaccine booster debate","author":"Dolgin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117179_b0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2023.117179_b0035","article-title":"Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities","author":"Cannalire","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1126\/science.abb7498","article-title":"Structure of the RNA-dependent RNA polymerase from COVID-19 virus","volume":"368","author":"Gao","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117179_b0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41392-021-00733-x","article-title":"Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies","volume":"6","author":"Zhou","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2023.117179_b0050","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117179_b0055","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2018.03.007","article-title":"Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?","volume":"150","author":"de Castro","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0060","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/13543776.2021.1880568","article-title":"SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19","volume":"31","author":"Vicenti","year":"2021","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2023.117179_b0070","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19 - Final Report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2023.117179_b0075","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117179_b0080","article-title":"Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice","author":"Schafer","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.bmc.2023.117179_b0085","article-title":"Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients","author":"Jayk Bernal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2023.117179_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/v13081585","article-title":"Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication","volume":"13","author":"Dejmek","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117179_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153440","article-title":"Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections","volume":"86","author":"Jin","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2023.117179_b0100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","article-title":"Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin","volume":"28","author":"Yin","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmc.2023.117179_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113622","article-title":"Discovery and optimization of 2-((1H-indol-3-yl)thio)-N-benzyl-acetamides as novel SARS-CoV-2 RdRp inhibitors","volume":"223","author":"Zhang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0110","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsinfecdis.1c00083","article-title":"Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp","volume":"7","author":"Zhao","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117179_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109211","article-title":"Roles of flavonoids against coronavirus infection","volume":"328","author":"Russo","year":"2020","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2023.117179_b0120","doi-asserted-by":"crossref","DOI":"10.3390\/v12020184","article-title":"Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)","volume":"12","author":"Lalani","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117179_b0125","doi-asserted-by":"crossref","unstructured":"Kaul, T. N.; Middleton, E., Jr.; Ogra, P. L., Antiviral effect of flavonoids on human viruses. J Med Virol 1985, 15 (1), 71\u201379. DOI: 10.1002\/jmv.1890150110.","DOI":"10.1002\/jmv.1890150110"},{"key":"10.1016\/j.bmc.2023.117179_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173759","article-title":"Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)","volume":"891","author":"Mouffouk","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117179_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173980","article-title":"Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2","volume":"25","author":"Muchtaridi","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117179_b0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ptr.7309","article-title":"Quercetin and its derivates as antiviral potentials: A comprehensive review","volume":"36","author":"Di Petrillo","year":"2022","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmc.2023.117179_b0145","doi-asserted-by":"crossref","unstructured":"Imran, M.; Thabet, H. K.; Alaqel, S. I.; Alzahrani, A. R.; Abida, A.; Alshammari, M. K.; Kamal, M.; Diwan, A.; Asdaq, S. M. B.; Alshehri, S., The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature. Antioxidants (Basel) 2022, 11 (5). DOI: 10.3390\/antiox11050876.","DOI":"10.3390\/antiox11050876"},{"key":"10.1016\/j.bmc.2023.117179_b0150","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/ptr.6887","article-title":"A role for quercetin in coronavirus disease 2019 (COVID-19)","volume":"35","author":"Derosa","year":"2021","journal-title":"Phytother Res"},{"key":"10.1016\/j.bmc.2023.117179_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpha.2021.09.009","article-title":"Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19","volume":"12","author":"Manjunath","year":"2022","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bmc.2023.117179_b0160","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1038\/s41598-022-14664-2","article-title":"Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase","volume":"12","author":"Munafo","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2023.117179_b0165","unstructured":"Schr\u00f6dinger Release 2021-4: Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2021; Impact, Schr\u00f6dinger, LLC, New York, NY; Prime, Schr\u00f6dinger, LLC, New York, NY, 2021."},{"key":"10.1016\/j.bmc.2023.117179_b0170","unstructured":"Schr\u00f6dinger Release 2021-3: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2021."},{"key":"10.1016\/j.bmc.2023.117179_b0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117179_b0180","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:21:54Z","timestamp":1760836914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"alternative-id":["S0968089623000275"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117179","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, docking, and biochemical characterization of non-nucleoside SARS-CoV-2 RdRp inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117179"}}